tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Katie Tryhane, 1 are a BUY (100%).
Analyst Katie Tryhane,
Katie Tryhane’s has documented 2 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRL, Charles River Laboratories at 25-Aug-2022.
Analyst best performing recommendations are on CRL (CHARLES RIVER LABORATORIES).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$155
$-4.4 (-2.76%)
$145
2 months 7 days ago
(07-May-2025)
6/6 (100%)
$13.64 (9.65%)
46
Hold
$170
$10.6 (6.65%)
$190
2 months 7 days ago
(07-May-2025)
2/6 (33.33%)
$28.64 (20.26%)
8
Hold
$140
$-19.4 (-12.17%)
$173
2 months 7 days ago
(07-May-2025)
12/15 (80%)
$-1.36 (-0.96%)
62
Hold
$155
$-4.4 (-2.76%)
$210
3 months 6 days ago
(08-Apr-2025)
3/3 (100%)
$15.93 (11.45%)
74
Buy
$170
$10.6 (6.65%)
$190
3 months 24 days ago
(20-Mar-2025)
0/4 (0%)
$2.72 (1.63%)
What Year was the first public recommendation made by Katie Tryhane?
